Join our daily newsletter At The Bell to receive exclusive market insights
- Nutritional Growth Solutions (NGS) has launched its Healthy Height store on Tmall Global, Alibaba’s business-to-consumer online platform
- The Tmall Global platform has the potential to introduce NGS products to more than half a billion Chinese consumers
- The company says the COVID-19 pandemic has encouraged the population of China to reconsider their dietary habits, thus opening new markets
- Nutritional Growth Solutions has operations in both Australia and Israel, developing nutritional supplement formulae specifically for children
- NGS is down 1.89 per cent today, trading at 26 cents
Nutritional Growth Solutions (NGS) has launched its Healthy Height store on Tmall Global, Alibaba’s business-to-consumer online platform.
The Tmall Global platform, designed specifically for international retailers, has the potential to introduce NGS products to more than half a billion Chinese consumers.
NGS is expecting Chinese consumers to respond positively to Healthy Height’s protein shakes for children, as they look to cash in on Asian demand for high- quality, international nutrition brands.
The company says the severity of the COVID-19 pandemic has encouraged the general population of China to reconsider their dietary habits. This has resulted in nutritional supplements being among the fastest-growing categories on Tmall Global during 2020 with monthly sales exceeding ¥1 billion (roughly A$200 million). Protein powders and amino acids were among the best selling products.
NGS Chairman Brian Leedman says, “investors have the opportunity to benefit from NGS’s direct exposure to the Chinese appetite for quality, nutritional health supplement products.”
“The Tmall Global platform provides our clinically proven products the opportunity to differentiate from our competitors in this vast market opportunity.”
Listing on the ASX last October, Nutritional Growth Solutions has operations in both Australia and Israel, developing nutritional supplement formulae for children. NGS believes parents with children aged three to twelve years old represent a large market opportunity, with the company aiming to differentiate itself from competitors by producing clinically tested products.
NGS is down 1.89 per cent today, trading at 26 cents at 9:50 am AEDT.
